-

Cresco Labs Opens New Sunnyside Dispensary in Daytona Beach, Florida

CHICAGO--(BUSINESS WIRE)--Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company), a vertically integrated multistate cannabis operator and the No. 1 U.S. wholesaler of branded products, today announced it has opened its newest Sunnyside dispensary in Daytona Beach, Florida, at 2110 W. International Speedway Blvd. Sunnyside Daytona Beach marks the Company’s 23rd dispensary in the state and 58th nationwide.

“Expanding our retail footprint and broadening the reach of our branded portfolio in a top market like Florida will continue to be one of our core focus areas in 2023,” said Charles Bachtell, Cresco Labs’ CEO & Co-Founder. “We chose this location because it is on a busy thoroughfare near Interstate 95 and across the street from the Daytona International Speedway, home of the Daytona 500, which creates many points for patients to access our top-quality cannabis products for their needs. We’re excited to open our first store in Daytona Beach and look forward to serving its patient community.”

Sunnyside Daytona Beach will offer a wide assortment of cannabis products from Cresco Labs’ branded portfolio that includes Cresco, One Plant, Supply (High Supply), Good News, Remedi and Sunnyside. The store also has a curated selection of accessories.

Patients can place orders today both in store and online through the retailer’s Sunnyside.shop website. Store hours are Monday through Saturday, 9 AM to 8 PM, and Sunday, 9 AM to 6 PM.

Cresco Labs operates 23 Sunnyside stores in Florida: Avon Park, Bonita Springs, Boynton Beach, Cape Coral, Clearwater, Daytona Beach, Fort Lauderdale, Jacksonville Beach, Lady Lake, Lutz, North Miami, Ocala, Oakland Park, Orlando (Fern Park, W. Orlando), Panama City Beach, Pensacola (9th Ave. and Nine Mile Rd.), Port St. Lucie, Sarasota, St. Petersburg, Tallahassee and Tampa.

For more information, visit www.Sunnyside.shop.

About Cresco Labs

Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms. Sunnyside, Cresco Labs’ national dispensary brand, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at www.crescolabs.com

Facebook: Cresco Labs

Twitter: Cresco Labs

LinkedIn: Cresco Labs

Contacts

Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com

Investors:
Megan Kulick, Cresco Labs
Senior Vice President, Investor Relations
investors@crescolabs.com

For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com

Cresco Labs

CNSX:CL

Release Versions

Contacts

Media:
Jason Erkes, Cresco Labs
Chief Communications Officer
press@crescolabs.com

Investors:
Megan Kulick, Cresco Labs
Senior Vice President, Investor Relations
investors@crescolabs.com

For general Cresco Labs inquiries:
312-929-0993
info@crescolabs.com

Social Media Profiles
More News From Cresco Labs

Cresco Labs CEO: Rescheduling Ushers in a New Era of Care for Medical Cannabis Patients

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today issued a statement on behalf of Cresco Labs CEO Charlie Bachtell in response to the Department of Justice’s final rule publication rescheduling medical cannabis from Schedule I to Schedule III under the Controlled Substances Act. “Rescheduling medical cannabis is a long-overdue step that finally brings federal policy closer to the science. For the first time in history, our fed...

Cresco Labs to Report First Quarter 2026 Financial Results on May 8, 2026

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced it will report financial results for the quarter ended March 31st, 2026 on Friday, May 8, 2026 before the market opens. The Company will host a conference call and webcast to discuss its financial results and provide investors with key bu...

Cresco Labs Opens Sunnyside Bridgeport, Expanding Access in the Ohio Valley

CHICAGO--(BUSINESS WIRE)--Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), today announced the grand opening of Sunnyside Bridgeport, located at 435 Main Street in Bridgeport, Ohio. It’s the Company’s seventh dispensary in Ohio and 73rd nationwide. “We’re proud to join the Bridgeport community and offer a positive, reliable shopper experience to the people of Belmont County,” said Charlie Bachtell, CEO of Cresco Labs. “Ohio is an important market for Cresco...
Back to Newsroom